134 related articles for article (PubMed ID: 37734854)
1. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma.
Estabrooks T; Gurinovich A; Pietruska J; Lewis B; Harvey G; Post G; Lambert L; Miller A; Rodrigues L; White ME; Lopes C; London CA; Megquier K
Vet Comp Oncol; 2023 Dec; 21(4):623-633. PubMed ID: 37734854
[TBL] [Abstract][Full Text] [Related]
2. Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.
Wong S; Ehrhart EJ; Stewart S; Zismann V; Cawley J; Halperin R; Briones N; Richter K; Sivaprakasam K; Perdigones N; Contente-Cuomo T; Facista S; Trent JM; Murtaza M; Khanna C; Hendricks WPD
PLoS One; 2022; 17(7):e0264986. PubMed ID: 35867969
[TBL] [Abstract][Full Text] [Related]
3. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma.
Gedney A; Salah P; Mahoney JA; Krick E; Martins R; Scavello H; Lenz JA; Atherton MJ
Vet Comp Oncol; 2022 Sep; 20(3):688-696. PubMed ID: 35442554
[TBL] [Abstract][Full Text] [Related]
5. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
[TBL] [Abstract][Full Text] [Related]
6. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO
Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
[TBL] [Abstract][Full Text] [Related]
7. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.
Wang G; Wu M; Durham AC; Radaelli E; Mason NJ; Xu X; Roth DB
PLoS One; 2020; 15(3):e0229728. PubMed ID: 32210430
[TBL] [Abstract][Full Text] [Related]
8. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
Davies O; Taylor AJ
Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma.
Sorenmo K; Samluk M; Clifford C; Baez J; Barrett JS; Poppenga R; Overley B; Skorupski K; Oberthaler K; Van Winkle T; Seiler G; Shofer F
J Vet Intern Med; 2007; 21(6):1347-54. PubMed ID: 18196746
[TBL] [Abstract][Full Text] [Related]
10. Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma.
Musser ML; Coto GM; Lingnan Y; Mochel JP; Johannes CM
PLoS One; 2022; 17(12):e0279594. PubMed ID: 36548371
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.
Kahn SA; Mullin CM; de Lorimier LP; Burgess KE; Risbon RE; Fred RM; Drobatz K; Clifford CA
Can Vet J; 2013 Mar; 54(3):237-42. PubMed ID: 23997259
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.
Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L
Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746
[TBL] [Abstract][Full Text] [Related]
13. Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014).
Batschinski K; Nobre A; Vargas-Mendez E; Tedardi MV; Cirillo J; Cestari G; Ubukata R; Dagli MLZ
Can Vet J; 2018 Sep; 59(9):967-972. PubMed ID: 30197439
[TBL] [Abstract][Full Text] [Related]
14. Actionable mutations in canine hemangiosarcoma.
Wang G; Wu M; Maloneyhuss MA; Wojcik J; Durham AC; Mason NJ; Roth DB
PLoS One; 2017; 12(11):e0188667. PubMed ID: 29190660
[TBL] [Abstract][Full Text] [Related]
15. Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.
Mukai C; Choi E; Sams KL; Klampen EZ; Anguish L; Marks BA; Rice EJ; Wang Z; Choate LA; Chou SP; Kato Y; Miller AD; Danko CG; Coonrod SA
BMC Vet Res; 2020 Jun; 16(1):206. PubMed ID: 32571313
[TBL] [Abstract][Full Text] [Related]
16. Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy.
Faroni E; Sabattini S; Guerra D; Iannuzzi C; Chalfon C; Agnoli C; Stefanello D; Polton G; Ramos S; Aralla M; Ciaccini R; Foglia A; Okonji S; Marconato L
Vet Comp Oncol; 2023 Mar; 21(1):123-130. PubMed ID: 36633399
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
[TBL] [Abstract][Full Text] [Related]
18. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S
J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
[TBL] [Abstract][Full Text] [Related]
19. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma.
Story AL; Wavreille V; Abrams B; Egan A; Cray M; Selmic LE
Vet Surg; 2020 Aug; 49(6):1154-1163. PubMed ID: 32562436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
